β-Adrenergic signal transduction in the failing and hypertrophied myocardium

Journal of Molecular Medicine

Volumn 75, Issue 11-12, 1997, Pages 842-848

  Böhm, Michael ^a   Flesch, Markus ^a   Schnabel, Petra ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adenylyl cyclase; Cardiac hypertrophy; G proteins; Heart failure; Sympathetic activation; Adrenoceptors

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; INOTROPISM; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC TONE;

EID: 0030729431     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050175     Document Type: Review

References (56)

1. Cohn JN (1989) The sympathetic nervous system in heart failure. J Cardiovasc Pharmacol 14 [Suppl 5]:57-61
2. Bayliss J, Norell M, Capena-Anson R et al (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57:17-21
3. Dzau V, Colucci W, Hollenberg N, Williams G (1981) Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63:645-656
4. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M (1972) Role of blood pressure in the development of congestive heart failure: the Framingham Study. N Engl J Med 287:781-787
5. Goldstein DS, Kopin IJ (1990) The autonomic nervous system and catecholamines in normal blood pressure control and in hypertension. In: Laragh JH, Brenner BM (eds) Hypertension pathophysiology: diagnosis and management. Raven, New York, pp 711-747
6. Gilman AG (1987) G proteins: transducers of receptor-generated signals. Ann Rev Biochem 56:615-649
7. Birnbaumer L (1990) G-proteins in signal transduction. Annu Rev Pharmacol Toxicol 30:675-705
8. Simon MI, Strathmann MP, Gautam N (1991) Diversity of G-proteins in signal transduction. Science 252:802-808
9. Camps M, Carozzi A, Schnabel P, Scheer A, Parker PJ, Gierschik P (1992) Isozyme-selective stimulation of phospholipase C-β2 by G-protein βγ-subunits. Nature 360:684-686
10. Tang WJ, Gilman AG (1991) Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science 254:1500-1503
11. Cohn JN, Levine TB, Olivari MT et al (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819-823
12. Francis GS, Goldsmith SR, Ziesche SM, Cohn JN (1982) Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol 49:1152-1159
13. Swedberg K, Viquerat C, Rouleau JL, Roizen M, Atherton B, Parmley WW, Chatterjee K (1984) Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol 54:783-789
14. Bristow MR, Anderson FL, Port DP, Skerl L, Hershberger RS, Larabee P, O'Conell JB, Renlund DG, Volkman K, Murray J, Feldman AM (1991) Differences in β-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 84:1024-1039
15. Böhm M, La Rosée K, Schwinger RHG, Erdmann E (1995) Evidence for a reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 25:146-153
16. Gille E, Lemoine H, Ehle B, Kaumann AJ (1985) The affinity of (-)-propanolol for β1- and β2-receptors of human hearts. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn-Schmiedebergs Arch Pharmacol 331:60-70
17. Hausdorff WP, Caron MG, Lefkowitz RJ (1990) Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J 4:2881-2889
18. Lohse MJ (1992) Mechanisms of β-adrenergic receptor desensitization. In: Hargave PA, Hofmann KP, Kaupp UB (eds) Signal transmission in photoreceptor systems. Springer, Berlin Heidelberg New York, pp 160-171
19. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (1990) β-Arrestin: a protein that regulates β-adrenergic receptor function. Science 248:1547-1550
20. Bristow MR, Ginsburg R, Minobe W, Cubiciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DE, Stinson EB (1982) Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 307: 205-211
21. Brodde OE (1991). β1- and β2-Adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203-242
22. Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 87:454-463
23. Bristow MR, Minobe WA, Raynolds MV, Port JD, Rasmussen R, Ray PE, Feldman AM (1993) Reduced β1-receptor messenger RNA abundance in the failing human heart. J Clin Invest 92:2737-2745
24. Böhm M (1995) Alterations of β-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure. Mol Cell Biochem 147:147-160
25. 3-adrenoceptor in the human heart. J Clin Invest 98:556-562
26. 3-adrenoceptor receptor gene. Mol Pharmacol 44:264-270
27. Strosberg AD (1993) Structure, function, and regulation of adrenoceptor receptors. Protein Sci 2:1198-1209
28. 3-adrenoceptors. Trends Pharmacol Sci 11:229-230
29. Feldman MD, Copelas L, Gwathmey JK, Philips P, Warren SE, Schoen FJ, Grossman W, Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75:331-339
30. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C (1988) Increase in the 40,000 mol wt pertussis toxin substrate (G-protein) in the failing human heart. Clin Invest 82:189-197
31. Seamon KB, Daly JW (1989) Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res 20:1-150
32. Tang WJ, Gilman AG (1992) Adenylyl cyclases. Cell 70:869-872
33. Taussig R, Quarmby LM, Gilman AG (1993) Regulation of purified type I and type II adenylylcyclases by G protein βγ subunits. J Biol Chem 268:9-12
34. Schnabel P, Böhm M, Gierschik P, Jakobs KH, Erdmann E (1990) Improvement of cholera toxin-catalyzed ADP-ribosylation by endogenous ADP-ribosylation factor from bovine brain provides evidence for an unchanged amount of Gsα in failing human myocardium. J Mol Cell Cardiol 22: 73-82
35. Eschenhagen T, Mende U, Nose M, Schmitz W, Scholz H, Haverich A, Hirt S, Döring V, Kalmar P, Höppner W, Seitz HJ (1992) Increased messenger RNA level of the inhibitory G-protein α-subunits Giα2 in human end-stage heart failure. Circ Res 70:688-696
36. Milligan G (1988) Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins. Biochem J 255:1-13
37. 1-Adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium. Circulation 83: 1343-1351
38. Neumann J, Scholz H, Döring V, Schmitz W, v. Meyerinck L, Kalmar P (1988) Increase in myocardial Gi-proteins in heart failure. Lancet II:936-937
39. Brown LA, Harding SE (1992) The effect of pertussis toxin on β-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea pigs and patients with cardiac failure. Br J Pharmacol 106:115-122
40. Grossman W, Jones D, McLaurin KP (1975) Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 58:56-64
41. Spann JF Jr, Buccino RA, Sonnenblick EH, Braunwald E (1967) Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ Res 21:341-454
42. Head RJ, Cassis LA, Robinson RL, Westfall DP, Stitzel RE (1985) Altered catecholamine contents in vascular and nonvascular tissues in genetically hypertensive rats. Blood Vessels 22:196-204
43. Howes LG, Summers RJ, Louis WJ (1986) The influence of age and sex on cardiac, renal and caudal artery catecholamine content in spontaneously hypertensive (SHR) and Wistar Kyoto (WKY) rats. J Auton Pharmacol 6:171-180
44. Kurtz TW, Montano M, Chan L, Kabra P (1989) Molecular evidence of genetic heterogenity in Wistar-Kyoto rats: implications for research with the spontaneously hypertensive rat. Hypertension 13:188-192
45. Ganten D, Lindpaintner K, Ganten U, Peters J, Zimmermann F, Bader M, Mullins J (1991) Transgenic rats: new animal models in hypertension research. Hypertension 17:843-855
46. Mullins JJ, Peters J, Ganten D (1990) Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541-544
47. Gende OA, Mattiazi A, Camilion MC, Pedroni P, Taquine C, Llambi HG, Cingolani HE (1985) Renal hypertension impairs inotropic isoproterenol effect without β-receptor changes. Am J Physiol 249:H814-H819
48. Murakami T, Katada T, Yasuda H (1987) Reduction in the activity of the stimulatory guanine nucleotide-binding protein in the myocardium of spontaneously hypertensive rats. J Mol Cell Cardiol 19:199-208
49. Woodcock EA, Funder JW, Johnston CI (1979) Decreased cardiac β-adrenergic receptors in deoxycorticosterone salt and renal hypertensive rats. Circ Res 45:560-565
50. Rapp JP, Wang SM, Dene H (1989) A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science 243:542-544
51. Ayobe MH, Tarazi RC (1984) Reversal of changes in myocardial β-receptors and inotropic responsiveness with regression of cardiac hypertrophy in renal hypertensive rats (RHR). Circ Res 54:125-134
52. Robberecht P, Winand J, Chatelain P, Poloczek P, Camus JC, De Neef P, Christophe J (1981) Comparison of β-adrenergic receptors and the adenylate cyclase system with muscarinic receptors and guanylate cyclase activities in the heart of spontaneously hypertensive rats. Biochem Pharmacol 30:385-387
53. Böhm M, Gierschik P, Knorr A, Larisch K, Weismann K, Erdmann E (1992) Desensitization of adenylate cyclase and increase of Giα in cardiac hypertrophy due to acquired hypertension. Hypertension 20:103-112
54. Böhm M, Moll M, Schmid B, Paul M, Ganten D, Castellano M, Erdmann E (1994) β-Adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension 24:653-662
55. Michel MC, Brodde OE, Insel PA (1990) Peripheral adrenergic receptors in hypertension. Hypertension 16:107-120
56. Böhm M, Kirchmayr R, Erdmann E (1995) Myocardial Giα-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock. Cardiovasc Res 30:611-618